Minimal Residual Disease Testing Current Innovations and Future Directions /

This volume provides a concise yet comprehensive overview of minimal residual disease (MRD) testing. The text reviews the history of MRD testing, MRD testing for acute lymphoblastic leukemia/lymphoma, molecular diagnostics for MRD analysis in hematopoietic malignancies, the use of "difference f...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Druley, Todd E. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2019.
Έκδοση:1st ed. 2019.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 02963nam a2200469 4500
001 978-3-319-94827-0
003 DE-He213
005 20191220130317.0
007 cr nn 008mamaa
008 181115s2019 gw | s |||| 0|eng d
020 |a 9783319948270  |9 978-3-319-94827-0 
024 7 |a 10.1007/978-3-319-94827-0  |2 doi 
040 |d GrThAP 
050 4 |a RB45 
072 7 |a MJF  |2 bicssc 
072 7 |a MED038000  |2 bisacsh 
072 7 |a MJF  |2 thema 
082 0 4 |a 616.15  |2 23 
245 1 0 |a Minimal Residual Disease Testing  |h [electronic resource] :  |b Current Innovations and Future Directions /  |c edited by Todd E. Druley. 
250 |a 1st ed. 2019. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2019. 
300 |a VIII, 197 p. 28 illus., 27 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Introduction -- Minimal Residual Disease Testing in Acute Lymphoblastic Leukemia/Lymphoma -- Molecular Diagnostics for Minimal Residual Disease Analysis in Hematopoietic Malignancies -- Monitoring AML Response Using "Difference From Normal" Flow Cytometry -- ML-DS: A Unique Condition for Measurable Residual Disease Detection -- Advancements in Next Generation Sequencing for Detecting Minimal Residual Disease. 
520 |a This volume provides a concise yet comprehensive overview of minimal residual disease (MRD) testing. The text reviews the history of MRD testing, MRD testing for acute lymphoblastic leukemia/lymphoma, molecular diagnostics for MRD analysis in hematopoietic malignancies, the use of "difference from normal" flow cytometry in monitoring AML response, ML-DS for measurable residual disease detection, and advancements in next generation sequencing for detecting MRD. Written by experts in the field, Minimal Residual Disease Testing: Current Innovations and Future Directions is a valuable resource for hematologists, oncologists, pathologists, and radiologists on the variety of technologies available to detect MRD and how best to integrate these platforms into clinical practice. 
650 0 |a Hematology. 
650 0 |a Oncology  . 
650 0 |a Pathology. 
650 1 4 |a Hematology.  |0 http://scigraph.springernature.com/things/product-market-codes/H3307X 
650 2 4 |a Oncology.  |0 http://scigraph.springernature.com/things/product-market-codes/H33160 
650 2 4 |a Pathology.  |0 http://scigraph.springernature.com/things/product-market-codes/H4800X 
700 1 |a Druley, Todd E.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319948263 
776 0 8 |i Printed edition:  |z 9783319948287 
856 4 0 |u https://doi.org/10.1007/978-3-319-94827-0  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)